Clinical Trial Update: Mortality Reduction After Oral Azithromycin Contingency: Mortality Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating an oral azithromycin contingency and its effect on mortality in childhood mortality cases; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Mortality

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Childhood Mortality | Phase 4 | Status: COMPLETED | Results posted: 2022-08-11